Neurocrine Biosciences
NBIX
#1544
Rank
NZ$19.01 B
Marketcap
$190.75
Share price
-0.07%
Change (1 day)
-17.07%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

We have found no dividend history for this company